From a single blood draw

Know your brain before it forgets you.

Track your brain health at home with the mNeuroMap app. Our blood-based NeuroMap analysis is available to institutions and clinicians through CLIA-certified partner laboratories.

mNeuroMap self-check score screen
How it works

From one routine blood draw to early insight

PathoBrainSeq reads molecular signals in blood with multi-omic AI.

①

One blood draw

No spinal taps, no scans. Just one routine sample.

②

Multi-omic AI integration

Multi-omic signals integrated by our models.

③

A clear summary

An easy-to-read summary for you and your clinician.

Our platform

Three ways we help

Conditions

What our models focus on

We only build what the data supports — and expand carefully as cohorts grow.

Current focus

Focus of our current models.

  • Alzheimer's disease
  • Dementia

Research · expanding

Active research areas — not yet available for assessment.

  • Parkinson's
  • Huntington's
  • ALS
  • Prion diseases

For institutions and clinicians via CLIA-certified partner labs. Not an FDA-cleared diagnostic test; not a substitute for a professional diagnosis.

For clinicians & researchers

Request a blood analysis

Submit an inquiry to run a sample through NeuroMapDx™.

Programs & Partners
B2B 1st place · 2023
Prize awarded by Hanwha Life DREAMPLUS
Member
AI startup program
Fellowship · Cohort 002
Foundry platform credits · 2026
Accelerator · 2025
Digital Health PMF program · exhibited at HLTH USA 2025